A limitation of our study is that it is correlative in nature: therefore, it is not possible either to demonstrate a clear causal link between AGEs accumulation and SREBP-1c activation or to identify which of the two factors (SCAP glycosylation vs hyperinsulinemia) has a greater effect on SREBP-1c expression. The gene discussed is SCAP; the disease is hyperinsulinism.